Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2009-07-07 (16 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: CAEN (14000), Calvados
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE SAINT-GILLES : revenue, balance sheet and financial ratios
PHARMACIE SAINT-GILLES is a French company
founded 16 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in CAEN (14000),
this company of category PME
shows in 2023 a net income positive of 37 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE SAINT-GILLES (SIREN 514130608)
Indicator
2023
2022
2019
2018
2017
2016
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
Net income
37 491 €
117 276 €
67 226 €
83 226 €
-128 499 €
44 580 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2023, PHARMACIE SAINT-GILLES generates positive net income of 37 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2023: 45 k€ -> 37 k€.
Net income (2023)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
37 491 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 61%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 55%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2023)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
61.454%
Financial autonomy (2023)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
54.88%
Asset age ratio (2023)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2022
2023
Debt ratio
199.431
243.764
176.507
142.409
74.36
61.454
Financial autonomy
30.156
25.629
32.198
36.393
49.315
54.88
Repayment capacity
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
61.452023
2019
2022
2023
Q1: 20.09
Med: 66.92
Q3: 169.24
Good-10 pts over 3 years
In 2023, the debt ratio of PHARMACIE SAINT-GILLES (61.45) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
54.88%2023
2019
2022
2023
Q1: 28.72%
Med: 48.51%
Q3: 68.17%
Good+14 pts over 3 years
In 2023, the financial autonomy of PHARMACIE SAINT-GILLES (54.9%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 221.27. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2023)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2022
2023
Liquidity ratio
47.799
134.401
143.439
154.426
209.102
221.267
Interest coverage
None
None
None
None
None
None
Sector positioning
Liquidity ratio
221.272023
2019
2022
2023
Q1: 135.25
Med: 189.78
Q3: 270.35
Good+16 pts over 3 years
In 2023, the liquidity ratio of PHARMACIE SAINT-GILLES (221.27) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Positioning of PHARMACIE SAINT-GILLES in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 220 transactions of similar company sales
in 2023,
the value of PHARMACIE SAINT-GILLES is estimated at
442 374 €
(range 269 028€ - 621 878€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2023
220 transactions
269k€442k€621k€
442 374 €Range: 269 028€ - 621 878€
NAF 5 année 2023
Valuation method used
Net Income Multiple
37 491 €
×
11.8x
=442 374 €
Range: 269 029€ - 621 879€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE SAINT-GILLES with other companies in the same sector:
Frequently asked questions about PHARMACIE SAINT-GILLES
What is the revenue of PHARMACIE SAINT-GILLES ?
The revenue of PHARMACIE SAINT-GILLES is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE SAINT-GILLES profitable?
Yes, PHARMACIE SAINT-GILLES generated a net profit of 37 k€ in 2023.
Where is the headquarters of PHARMACIE SAINT-GILLES ?
The headquarters of PHARMACIE SAINT-GILLES is located in CAEN (14000), in the department Calvados.
Where to find the tax return of PHARMACIE SAINT-GILLES ?
The tax return of PHARMACIE SAINT-GILLES is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE SAINT-GILLES operate?
PHARMACIE SAINT-GILLES operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart